Observational Clinical Study on the Association Between Lactate-mediated Gut Microbiota Alterations and Disease Progression in Liver Cirrhosis.

ConditionCirrhosis

Trial statusNot yet recruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18-80

SponsorZhujiang Hospital

About this trial

To investigate the association between lactate-mediated alterations in the gut microbiota and disease progression in patients with liver cirrhosis; and to examine the correlations of lactate levels among serum, fecal, and tissue samples in patients with liver cirrhosis.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

None

Disqualifiers

1. A history of severe organic diseases involving the liver, gastrointestinal tract, kidneys, or other organ systems; malignant tumors; or autoimmune diseases.

Trial population

Meet eligibility criteria

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

observational study, no intervention
Other intervention
observational study, no intervention

Treatment groups

200 Participants

are divided into 2 treatment groups

Group A: Cirrhosis1 intervention

Group B: Healthy control1 intervention

Trial outcomes

Primary outcomes

Gut microbiota composition

Time frame

baseline

Lactate level

Time frame

baseline

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Zhujiang Hospital

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: